Meeting Details - The fifth meeting of the Supervisory Board of Beijing Saiseng Pharmaceutical Co., Ltd. was held on June 19, 2025, with all three attending supervisors present [1][2] - The meeting was legally convened in accordance with relevant laws and regulations [1] Resolutions Passed - The Supervisory Board approved the proposal regarding the signing of a "New Drug Technology Transfer Contract" and related transactions [1][2] - The board confirmed that the transaction is necessary for the company's normal operations and aligns with its development strategy [2] Compliance and Impact - The Supervisory Board concluded that the transaction complies with legal and regulatory requirements and does not affect the company's independence or harm the interests of shareholders, particularly minority shareholders [2]

Core Viewpoint - The company has responded to the Shanghai Stock Exchange regarding its 2024 annual report, specifically addressing issues related to related party transactions and providing detailed disclosures on procurement and sales activities with its controlling shareholder and affiliates [1][2]. Related Party Transactions - In 2024, the company engaged in related party transactions amounting to 12.028 billion yuan, with related party purchases reaching 9.837 billion yuan, a year-on-year increase of 36.24%, and related party sales totaling 2.159 billion yuan [2]. - The company provided a detailed breakdown of its top five related party purchases, indicating that the prices for related party transactions were generally in line with market prices, demonstrating fairness in pricing [4][5]. Procurement Details - The top five related party procurement items included products such as benzene, caprolactam, and raw coal, which accounted for approximately 69.62% of total procurement [4]. - The increase in related party procurement was attributed to new equipment purchases for ongoing projects and stable procurement needs for raw materials [7]. Sales Activities - The company reported that its sales to related parties included products like nylon 66 chips and industrial yarn, with a significant portion of sales being directly shipped to end customers [9][10]. - The revenue from related party sales was confirmed to comply with accounting standards, with control over the products transferring to buyers at the point of delivery [10][11]. Financial Performance - The company’s total revenue from various products in 2024 was 1.384 billion yuan, with related party sales accounting for 215.892 million yuan, representing 15.59% of total revenue [9][11]. - The gross margin for certain products sold through related parties was reported, indicating a strategic approach to mitigate competition risks and optimize the supply chain [11][12]. Compliance and Risk Management - The company emphasized that its related party transactions were conducted based on normal business needs and adhered to market principles, ensuring no potential for profit transfer [8][12]. - The company has implemented measures to avoid competition with its affiliates by centralizing procurement and sales processes, thereby enhancing operational efficiency [11][12].

Core Viewpoint - The acquisition of Hefei Zhongke Junda Vision Technology Co., Ltd. by Fuhuang Steel Structure marks a strategic move to enter the high-speed vision sector, aiming to create a second growth curve amidst declining revenues and profits over the past three years [1][2]. Company Performance and Financials - Fuhuang Steel has faced continuous revenue and net profit declines for three consecutive years, with revenues of 4.74 billion yuan in 2022, 4.64 billion yuan in 2023, and projected 3.94 billion yuan in 2024, representing declines of 17.08%, 2.58%, and 15.06% respectively [3][4]. - The company's net profit has also decreased significantly, with figures of 97.49 million yuan in 2022, 96.05 million yuan in 2023, and 51.37 million yuan in 2024, showing declines of 41.31%, 1.48%, and 46.51% respectively [3][4]. - In the first quarter of 2023, Fuhuang Steel reported a slight revenue increase to 933 million yuan and a net profit of 17.42 million yuan, marking year-on-year growth of 1.65% and 4.04% respectively, but still below 2023 levels [4]. Acquisition Details - The acquisition price for Zhongke Junda is set at 1.14 billion yuan, with Fuhuang Steel planning to raise up to 400 million yuan from specific investors to support the transaction [2][6]. - The transaction is characterized as a related party transaction, as both companies share the same controlling shareholder, which raises concerns about asset valuation and potential conflicts of interest [6][7]. - The valuation of Zhongke Junda has increased nearly eightfold since Fuhuang Steel's previous sale of its stake in 2019, from 130 million yuan to 1.14 billion yuan [7][8]. Debt and Financial Pressure - Fuhuang Steel is currently under significant financial strain, with a debt-to-asset ratio of 67.46% and short-term borrowings exceeding 3.34 billion yuan, while cash reserves stand at only 767 million yuan, resulting in a funding gap of 2.57 billion yuan [9][10]. - The company has seen its interest-bearing debt rise from 2.15 billion yuan in 2020 to 3.69 billion yuan in 2024, leading to increased interest expenses [9]. Future Outlook and Performance Guarantees - The acquisition includes a performance compensation agreement, where Zhongke Junda commits to achieving net profits of at least 333.65 million yuan, 507.65 million yuan, and 731.64 million yuan from 2025 to 2027, totaling no less than 1.5 billion yuan [12].

Group 1 - The company, Beijing Construction Environment Remediation Co., Ltd., has formed a joint venture with Hefei Dongxin Jianbang Environmental Remediation Co., Ltd. to participate in the bidding for the "Jingxian Langqiao Town Wuxi Gold Mine Soil Pollution Source Comprehensive Treatment EPC Project," with a winning bid amount of 32.76 million yuan [1][2] - The transaction is classified as a related party transaction, as Dongxin Jianbang is a related legal entity due to the directorship of its board member [1][3] - The project is within the scope of the company's recent audited net assets, not exceeding 5%, and does not require shareholder approval [2][6] Group 2 - The financial data of Dongxin Jianbang for the year 2024 shows a net asset of approximately 5.51 million yuan, operating income of about 3.83 million yuan, and a net loss of approximately 6.31 million yuan [3] - The joint venture has previously won the "Hefei Paper Mill Soil Remediation Project" in February 2025, with a bid amount of approximately 32.88 million yuan, where the company undertook 30% of the workload [5][6] - The pricing policy for the related party transaction is based on normal business operations and is determined through public bidding, ensuring fair pricing [4][6] Group 3 - The main content of the contract includes payment terms for design and construction fees, with specific percentages outlined for progress payments and quality assurance [4][5] - The total project duration is set at 210 calendar days, with the company taking the lead in project design and coordination, while Dongxin Jianbang will assist in construction activities [5] - The transaction is deemed necessary for the operational needs of both parties and is expected to have no adverse impact on the company's independence or operations [6][7]

Core Viewpoint - The company intends to sign a related party transaction contract with China Life Insurance Group and its subsidiaries, with a total contract amount of 8.7 million yuan (including VAT) for the "China Life New Generation Human Resource Management System Phase II Project" [1][2] Summary by Sections Related Party Transaction Overview - The contract amount for the related party transaction is 8.7 million yuan (including VAT) [1] - The transaction involves multiple entities under China Life Insurance Group, including China Life Insurance Co., Ltd. and its subsidiaries [2] Related Party Identification and Relationship - China Life Insurance Group holds 20.34% of the company's shares, making it the largest shareholder [2] - The transaction is classified as a related party transaction under the Shenzhen Stock Exchange regulations [2] Transaction Amount and Approval Process - Cumulative related party transaction amounts since December 27, 2024, including this transaction, total 20,848,613 yuan, exceeding 0.5% of the company's latest audited net assets [3] - The board of directors approved the transaction on June 19, 2025, with independent directors unanimously agreeing to the proposal [3][14] Pricing Policy and Agreement Details - The transaction follows normal commercial practices, with pricing determined based on market standards, ensuring fairness and reasonableness [10][13] - The contract stipulates payment in four installments, totaling 8.7 million yuan, with specific conditions for each payment [11][12] Purpose and Impact on the Company - The transaction is deemed necessary for the company's operational activities and will not significantly impact its business independence or financial condition [13] - The total amount of related party transactions for the year to date is 9,459,817.37 yuan [13] Review Procedures - Independent directors and the board of supervisors have reviewed and approved the transaction, confirming compliance with relevant laws and regulations [14][15]

证券代码：301082 证券简称：久盛电气 公告编号：2025-026 久盛电气股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、关联交易概述 司"）召开第六届董事会第五次会议，审议通过了《关于接受控股股东财务资助 暨关联交易的议案》。为支持公司及子公司开展业务，公司控股股东湖州迪科实 业投资有限公司（以下简称"迪科投资"）以现金方式向公司及子公司提供总额 不超过 1 亿元的财务资助，期限自公司第六届董事会第五次会议审议通过之日起 利率（LPR）执行，公司可以根据实际情况在财务资助的期限及额度内连续循环 使用。公司就本次接受财务资助无需提供保证、抵押、质押等任何形式的担保。 据此测算，本次关联交易金额不超过 1.03 亿元（其中应支付年利息不超过 300 万元）。 股股东。根据《深圳证券交易所创业板股票上市规则》的规定，本次交易构成关 联交易。 于接受控股股东财务资助暨关联交易的议案》。关联董事张建华、张哲烨回避表 决，其余 5 名非关联董事均表决同意该议案。该项议案在提交公司董事会审议 前，已经公司独立董事专门会议审议，全体独立董事一致同意将 ...

圳证劵交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号 ——创业板上市公司规范运作》等有关法律、法规、规范性文件的有关规定及《久盛 电气股份有限公司章程》 （以下简称"《公司章程》"），结合公司实际情况，制定本规则。 第二条 公司与关联人之间的关联交易除遵守有关法律、法规、规范性文件及公 司章程的规定外，还需遵守本规则的有关规定。 第三条 公司与关联人之间的关联交易应签订书面协议。协议内容应明确、具体。 久盛电气股份有限公司 第一章 总 则 第一条 为保证久盛电气股份有限公司（以下简称"公司"）与关联方之间的关联 交易符合公平、公正、公开的原则，严格执行中国证券监督管理委员会（以下简称"中 国证监会"）有关规范关联交易行为的规定，确保公司的关联交易行为不损害公司和 非关联股东的合法权益，根据《中华人民共和国公司法》 《中华人民共和国证券法》 《深 第四条 关联交易活动应遵循诚实信用、平等、自愿、等价、有偿、公平、公正、 公开的原则，关联交易的价格原则上不能偏离市场独立第三方的价格或收费的标准， 对于难以比较市场价格或定价受到限制的关联交易，应通过合同明确有关成本和利润 的标准；公司应对 ...

证券代码：301082 证券简称：久盛电气 公告编号：2025-024 久盛电气股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 久盛电气股份有限公司（以下简称"公司"）第六届监事会第五次会议于 2025 年 6 月 19 日在公司会议室以现场方式召开。会议通知已于 2025 年 6 月 13 日以 即时通讯工具、电话等方式送达全体监事。本次会议由监事会主席孙利女士召集 并主持，会议应出席监事 3 人，实际出席监事 3 人。 《中华人民共和国证券法》 《深圳证券交易所 创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业 板上市公司规范运作》《上市公司章程指引》等相关法律法规及规范性文件，结 合公司实际情况，公司拟对《公司章程》相应条款进行修订。 本议案尚需提交公司 2025 年第一次临时股东大会。 本次会议的通知、召集、召开和表决程序符合《中华人民共和国公司法》 《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 《公司章程》等有关规定，本次监事会会议决议 合法有效。 二、监 ...

Group 1 - The company, Wanda Information, plans to sign a contract for the "China Life New Generation Human Resource Management System Phase II Project" with China Life Insurance (Group) Company, with a contract amount of 8.7 million yuan (including VAT) [1] - This related party transaction does not constitute a major asset reorganization and does not require approval from relevant authorities [1] - The cumulative amount of related party transactions between the company and the related party, including this transaction, will reach 20.8486 million yuan starting from December 27, 2024, exceeding 0.5% of the company's most recent audited net assets [1] Group 2 - This related party transaction requires approval from the company's board of directors but does not need to be submitted to the shareholders' meeting for approval [1]

Group 1 - The core opinion of the independent directors is that the signing of the "Fourth Phase Service Contract" between the subsidiary Haita Semiconductor and SK Hynix is beneficial for the company's sustained profitability and development in the semiconductor business [1] - The pricing of the related party transaction is fair and reasonable, and the decision-making process complies with legal regulations and the company's articles of association, ensuring no harm to the interests of shareholders, especially minority shareholders [1] - The independent directors agree to submit the proposal regarding the signing of the "Fourth Phase Service Contract" to the company's second extraordinary general meeting in 2025 for review [1] Group 2 - The capital increase decision is made to ensure the normal operational funding needs without causing financial pressure on existing business activities [2] - The pricing of the related party transaction is fair and reasonable, with no harm to the interests of the company and its shareholders, particularly minority shareholders [2] - The board's review and voting procedures are legal and effective, agreeing to submit the proposal regarding the capital increase in the investment fund for review [2]